To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

The blood group B type-4 … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

The blood group B type-4 heptaglycosylceramide is a minor blood group B structure in human B kidneys in contrast to the corresponding A type-4 compound in A kidneys. Structural and in vitro biosynthetic studies.

Journal article
Authors Jan Holgersson
Annika E. Bäcker
Michael Breimer
Mikael Gustafsson
Per-Åke Jovall
Hasse Karlsson
W Pimlott
Bo Samuelsson
Published in Biochimica et biophysica acta
Volume 1180
Issue 1
Pages 33-43
ISSN 0006-3002
Publication year 1992
Published at Institute of Medical Biochemistry
Pages 33-43
Language en
Keywords ABO Blood-Group System, Antigens, immunology, Carbohydrate Conformation, Carbohydrate Sequence, Ceramides, analysis, chemistry, immunology, Chromatography, Thin Layer, Gas Chromatography-Mass Spectrometry, Glycolipids, analysis, chemistry, immunology, Humans, Kidney, chemistry, immunology, Magnetic Resonance Spectroscopy, Molecular Sequence Data
Subject categories Clinical Medicine


Blood group A glycolipid antigens have been found based upon at least four different core saccharides (types 1 to 4). The biological significance of this structural polymorphism is not known, although the successful outcome of transplantations of blood group A2 kidneys to blood group O individuals have been partly explained by the low expression of A type-3 and -4 chain glycolipid antigens in A2 kidneys. If graft rejection due to ABO incompatibility is, in any way, correlated to the expression of type-3 and -4 chain blood group glycolipids, it is of interest to identify possible blood group B structures based on these core saccharides. In a non-acid glycosphingolipid fraction isolated from human blood group B kidneys, mass spectrometry, high-temperature gas chromatography-mass spectrometry and probing of thin-layer chromatograms with Gal alpha 1-4Gal-specific Escherichia coli and monoclonal anti-B antibodies provided evidence for minute amounts of a Gal alpha 1-3(Fuc alpha 1-2)Gal beta-HexNAc-Gal alpha 1-4Gal beta-Hex-Ceramide structure consistent with a B type-4 chain heptaglycosylceramide. In contrast, blood group A kidneys have the corresponding A type-4 chain heptaglycosylceramide as the predominant blood group A glycolipid. No, or very low activity of the blood group B gene enzyme on the type-4 chain blood group H hexaglycosylceramide precursor was found by biosynthetic experiments in vitro, which might explain the low expression of type-4 chain blood group B heptaglycosylceramides in human blood group B kidneys.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?